ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 910

$783K Total Retail Price of All Prescriptions

Rank: 47 out of 910

872 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 872 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 872 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 12,558 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 939 847 1 1
LISINOPRIL 625 563 2 2
OMEPRAZOLE 387 345 3 5
AMLODIPINE BESYLATE 379 372 4 4
WARFARIN SODIUM 362 346 5 11
HYDROCODONE-ACETAMINOPHEN 335 288 S3 6 8
ATENOLOL 319 297 7 10
ALLOPURINOL 310 283 8 33
FUROSEMIDE 303 276 9 9
LOVASTATIN 301 265 10 20
CITALOPRAM HBR 290 254 11 19
PRAVASTATIN SODIUM 290 271 11 16
SIMVASTATIN 288 260 13 3
METOPROLOL TARTRATE 255 248 14 7
METFORMIN HCL 232 197 15 6
GABAPENTIN 228 216 16 13
ATORVASTATIN CALCIUM 192 183 17 14
ALENDRONATE SODIUM 186 171 18 22
HYDROCHLOROTHIAZIDE 186 153 18 12
RANITIDINE HCL 185 156 20 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 151 21 44
ZOLPIDEM TARTRATE 174 152 22 17
METFORMIN HCL ER 162 132 23 77
LOSARTAN POTASSIUM 157 146 24 15
METOPROLOL SUCCINATE 152 134 25 21
FENOFIBRATE 143 122 26 55
TAMSULOSIN HCL 137 127 27 29
CLOPIDOGREL 137 133 27 35
PLAVIX 133 130 29 53
CARVEDILOL 130 121 30 36
POTASSIUM CHLORIDE 126 112 31 18
SPIRONOLACTONE 122 105 32 66
CYMBALTA 117 82 33 58
TERAZOSIN HCL 98 97 34 61
PANTOPRAZOLE SODIUM 97 92 35 27
AMITRIPTYLINE HCL 96 84 R 36 72
ISOSORBIDE MONONITRATE ER 82 71 37 81
BENICAR 80 80 38 94
CARISOPRODOL 79 58 R 39 71
CRESTOR 79 76 39 26
SYNTHROID 70 68 41 54
HYDRALAZINE HCL 68 55 42 65
FINASTERIDE 66 66 43 59
DILTIAZEM ER 65 53 44 105
GLIPIZIDE ER 65 59 44 87
ESTRADIOL 63 48 R 46 92
FLUOXETINE HCL 60 46 47 49
CYCLOBENZAPRINE HCL 59 47 R 48 80
OXYCODONE-ACETAMINOPHEN 58 40 S2 49 31
LOSARTAN-HYDROCHLOROTHIAZIDE 57 55 50 79
JANUVIA 57 56 50 69
CEPHALEXIN 57 55 50 90
BENICAR HCT 54 54 53 167
LEVOXYL 53 52 54 106
TRAMADOL HCL 51 48 55 25
GEMFIBROZIL 50 48 56 63
KLOR-CON M20 50 47 56 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.